Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Oncology
Published in: International Journal of Clinical Oncology 5/2006

01-10-2006 | CASE REPORT

Salivary gland carcinoma treated with concomitant chemoradiation with intraarterial cisplatin and docetaxel

Authors: Shin-ichiro Maruya, Atsushi Namba, Atsushi Matsubara, Seiji Kakehata, Ikuko Takeda, Takashi Shirasaki, Yoshiomi Hatayama, Morio Nagahata, Junkichi Yokoyama, Hideichi Shinkawa

Published in: International Journal of Clinical Oncology | Issue 5/2006

Login to get access
Metadata
Title
Salivary gland carcinoma treated with concomitant chemoradiation with intraarterial cisplatin and docetaxel
Authors
Shin-ichiro Maruya
Atsushi Namba
Atsushi Matsubara
Seiji Kakehata
Ikuko Takeda
Takashi Shirasaki
Yoshiomi Hatayama
Morio Nagahata
Junkichi Yokoyama
Hideichi Shinkawa
Publication date
01-10-2006
Publisher
Springer-Verlag
Published in
International Journal of Clinical Oncology / Issue 5/2006
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-006-0587-0

Other articles of this Issue 5/2006

International Journal of Clinical Oncology 5/2006 Go to the issue

CASE REPORT

Pseudomyxoma peritonei due to mucinous cystadenocarcinoma in situ of the urachus presenting as an inguinal hernia

CASE REPORT

Successful treatment of malignant pericardial effusion, using weekly paclitaxel, in a patient with breast cancer

REVIEW ARTICLE

Function-preserving surgery for breast cancer

REVIEW ARTICLE

Function-preserving surgery for gastric cancer

ORIGINAL ARTICLE

Results of radiation therapy combined with neoadjuvant hormonal therapy for stage III prostate cancer: comparison of two different definitions of PSA failure

ORIGINAL ARTICLE

Retrospective analysis of stage IV advanced gastric cancer treated with S-1 or other chemotherapy
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits